Two Sigma Advisers’s Global Cord Blood Corporation CO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-11,400
| Closed | -$34.1K | – | 2782 |
|
|
2023
Q1 | $34.1K | Hold |
11,400
| – | – | ﹤0.01% | 2480 |
|
|
2022
Q4 | $34.1K | Hold |
11,400
| – | – | ﹤0.01% | 2392 |
|
|
2022
Q3 | $34K | Hold |
11,400
| – | – | ﹤0.01% | 2407 |
|
|
2022
Q2 | $34K | Sell |
11,400
-100
| -0.9% | -$310 | ﹤0.01% | 2512 |
|
|
2022
Q1 | $44K | Sell |
11,500
-1,900
| -14% | -$7.89K | ﹤0.01% | 2601 |
|
|
2021
Q4 | $56K | Buy |
13,400
+1,000
| +8% | +$4.25K | ﹤0.01% | 2465 |
|
|
2021
Q3 | $58K | Buy |
+12,400
| New | +$60.8K | ﹤0.01% | 2361 |
|
|
2020
Q3 | – | Sell |
-46,378
| Closed | -$144K | – | 2747 |
|
|
2020
Q2 | $144K | Sell |
46,378
-200
| -0.4% | -$581 | ﹤0.01% | 2309 |
|
|
2020
Q1 | $148K | Sell |
46,578
-700
| -1% | -$3.06K | ﹤0.01% | 2245 |
|
|
2019
Q4 | $236K | Sell |
47,278
-6,400
| -12% | -$30.6K | ﹤0.01% | 2132 |
|
|
2019
Q3 | $260K | Sell |
53,678
-1,200
| -2% | -$6.29K | ﹤0.01% | 1969 |
|
|
2019
Q2 | $317K | Sell |
54,878
-20,709
| -27% | -$137K | ﹤0.01% | 1994 |
|
|
2019
Q1 | $531K | Buy |
75,587
+9,209
| +14% | +$60.9K | ﹤0.01% | 1775 |
|
|
2018
Q4 | $428K | Sell |
66,378
-15,609
| -19% | -$99.7K | ﹤0.01% | 1834 |
|
|
2018
Q3 | $573K | Buy |
81,987
+13,487
| +20% | +$101K | ﹤0.01% | 1739 |
|
|
2018
Q2 | $650K | Sell |
68,500
-44,800
| -40% | -$429K | ﹤0.01% | 1812 |
|
|
2018
Q1 | $1.16M | Sell |
113,300
-39,700
| -26% | -$406K | ﹤0.01% | 1484 |
|
|
2017
Q4 | $1.52M | Buy |
153,000
+8,948
| +6% | +$97.8K | ﹤0.01% | 1366 |
|
|
2017
Q3 | $1.6M | Buy |
144,052
+120,452
| +510% | +$1.41M | ﹤0.01% | 1314 |
|
|
2017
Q2 | $224K | Buy |
+23,600
| New | +$188K | ﹤0.01% | 2086 |
|
|
2016
Q4 | – | Sell |
-10,400
| Closed | -$53K | – | 2515 |
|
|
2016
Q3 | $53K | Sell |
10,400
-100
| -1% | -$533 | ﹤0.01% | 2170 |
|
|
2016
Q2 | $60K | Sell |
10,500
-600
| -5% | -$3.65K | ﹤0.01% | 2005 |
|
|
2016
Q1 | $67K | Sell |
11,100
-23,300
| -68% | -$139K | ﹤0.01% | 1976 |
|
|
2015
Q4 | $219K | Sell |
34,400
-7,502
| -18% | -$47.4K | ﹤0.01% | 1633 |
|
|
2015
Q3 | $254K | Buy |
+41,902
| New | +$260K | ﹤0.01% | 1558 |
|
Other funds holding CO
UB
OA
SPIA
Two Sigma Advisers's CO Position: Q2 2023 in Review
Two Sigma Advisers sold out of Global Cord Blood Corporation (CO) in Q2 2023, closing a stake of 11,400 shares — an estimated $34.1K sold.
Two Sigma Advisers first reported a position in CO in Q3 2015 and held it in 25 quarters. The position peaked at $1.6M in Q3 2017. 6 funds tracked by Wall St. Rank hold CO as of Q2 2023.
- Two Sigma Advisers reported no remaining Global Cord Blood Corporation position as of Q2 2023 after selling out during the quarter.
- Two Sigma Advisers sold 11,400 Global Cord Blood Corporation shares in Q2 2023, an estimated $34.1K.
- Two Sigma Advisers first reported a position in Global Cord Blood Corporation in Q3 2015 and held it in 25 quarters.
- Two Sigma Advisers's Global Cord Blood Corporation position peaked at $1.6M in Q3 2017.
- 6 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2023.
Based on Two Sigma Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.